Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction

Detalhes bibliográficos
Autor(a) principal: Minicucci, Marcos Ferreira [UNESP]
Data de Publicação: 2013
Outros Autores: dos Santos, Priscila P. [UNESP], Rafacho, Bruna P. M. [UNESP], Gonçalves, Andrea F. [UNESP], Silva, Renata A. C. [UNESP], Chiuso-Minicucci, Fernanda, Gaiolla, Paula Schmidt Azevedo [UNESP], Polegato, Bertha Furlan [UNESP], Okoshi, Katashi [UNESP], Pereira, Elenize J. [UNESP], Paiva, Sergio Alberto Rupp de [UNESP], Zornoff, Leonardo Antonio Mamede [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1371/journal.pone.0076866
http://hdl.handle.net/11449/76670
Resumo: Introduction:Our objective was to analyze the effect of spironolactone on cardiac remodeling after experimental myocardial infarction (MI), assessed by matricellular proteins levels, cardiac collagen amount and distribution, myocardial tissue metalloproteinase inhibitor-1(TIMP-1) concentration, myocyte hypertrophy, left ventricular architecture, and in vitro and in vivo cardiac function.Methods:Wistar rats were assigned to 4 groups: control group, in which animals were submitted to simulated surgery (SHAM group; n=9); group that received spironolactone and in which animals were submitted to simulated surgery (SHAM-S group, n=9); myocardial infarction group, in which animals were submitted to coronary artery ligation (MI group, n=15); and myocardial infarction group with spironolactone supplementation (MI-S group, n=15). The rats were observed for 3 months.Results:The MI group had higher values of left cardiac chambers and mass index and lower relative wall thicknesses compared with the SHAM group. In addition, diastolic and systolic functions were worse in the MI groups. However, spironolactone did not influence any of these variables. The MI-S group had a lower myocardial hydroxyproline concentration and myocyte cross-sectional area compared with the MI group. Myocardial periostin and collagen type III were lower in the MI-S group compared with the MI-group. In addition, TIMP-1 concentration in myocardium was higher in the MI-S group compared with the MI group.Conclusions:The predominant consequence of spironolactone supplementation after MI is related to reductions in collagens, with discrete attenuation of other remodeling variables. Importantly, this effect may be modulated by periostin and TIMP-1 levels. © 2013 Minicucci et al.
id UNSP_05e855e0ac2d268b912703d989fee1a7
oai_identifier_str oai:repositorio.unesp.br:11449/76670
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial InfarctionIntroduction:Our objective was to analyze the effect of spironolactone on cardiac remodeling after experimental myocardial infarction (MI), assessed by matricellular proteins levels, cardiac collagen amount and distribution, myocardial tissue metalloproteinase inhibitor-1(TIMP-1) concentration, myocyte hypertrophy, left ventricular architecture, and in vitro and in vivo cardiac function.Methods:Wistar rats were assigned to 4 groups: control group, in which animals were submitted to simulated surgery (SHAM group; n=9); group that received spironolactone and in which animals were submitted to simulated surgery (SHAM-S group, n=9); myocardial infarction group, in which animals were submitted to coronary artery ligation (MI group, n=15); and myocardial infarction group with spironolactone supplementation (MI-S group, n=15). The rats were observed for 3 months.Results:The MI group had higher values of left cardiac chambers and mass index and lower relative wall thicknesses compared with the SHAM group. In addition, diastolic and systolic functions were worse in the MI groups. However, spironolactone did not influence any of these variables. The MI-S group had a lower myocardial hydroxyproline concentration and myocyte cross-sectional area compared with the MI group. Myocardial periostin and collagen type III were lower in the MI-S group compared with the MI-group. In addition, TIMP-1 concentration in myocardium was higher in the MI-S group compared with the MI group.Conclusions:The predominant consequence of spironolactone supplementation after MI is related to reductions in collagens, with discrete attenuation of other remodeling variables. Importantly, this effect may be modulated by periostin and TIMP-1 levels. © 2013 Minicucci et al.Internal Medicine Department Botucatu Medical School University Estadual Paulista, Botucatu, São PauloDepartment of Microbiology and Immunology Institute of Biosciences University Estadual, Paulista, Botucatu, São PauloInternal Medicine Department Botucatu Medical School University Estadual Paulista, Botucatu, São PauloUniversidade Estadual Paulista (Unesp)University EstadualMinicucci, Marcos Ferreira [UNESP]dos Santos, Priscila P. [UNESP]Rafacho, Bruna P. M. [UNESP]Gonçalves, Andrea F. [UNESP]Silva, Renata A. C. [UNESP]Chiuso-Minicucci, FernandaGaiolla, Paula Schmidt Azevedo [UNESP]Polegato, Bertha Furlan [UNESP]Okoshi, Katashi [UNESP]Pereira, Elenize J. [UNESP]Paiva, Sergio Alberto Rupp de [UNESP]Zornoff, Leonardo Antonio Mamede [UNESP]2014-05-27T11:30:45Z2014-05-27T11:30:45Z2013-09-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://dx.doi.org/10.1371/journal.pone.0076866PLoS ONE, v. 8, n. 9, 2013.1932-6203http://hdl.handle.net/11449/7667010.1371/journal.pone.0076866WOS:0003254235001792-s2.0-848847320412-s2.0-84884732041.pdf15909715763094205016839015394547121314080140264774387040344716730000-0002-5843-6232Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengPLOS ONE2.7661,164info:eu-repo/semantics/openAccess2023-11-22T06:13:28Zoai:repositorio.unesp.br:11449/76670Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462023-11-22T06:13:28Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction
title Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction
spellingShingle Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction
Minicucci, Marcos Ferreira [UNESP]
title_short Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction
title_full Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction
title_fullStr Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction
title_full_unstemmed Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction
title_sort Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction
author Minicucci, Marcos Ferreira [UNESP]
author_facet Minicucci, Marcos Ferreira [UNESP]
dos Santos, Priscila P. [UNESP]
Rafacho, Bruna P. M. [UNESP]
Gonçalves, Andrea F. [UNESP]
Silva, Renata A. C. [UNESP]
Chiuso-Minicucci, Fernanda
Gaiolla, Paula Schmidt Azevedo [UNESP]
Polegato, Bertha Furlan [UNESP]
Okoshi, Katashi [UNESP]
Pereira, Elenize J. [UNESP]
Paiva, Sergio Alberto Rupp de [UNESP]
Zornoff, Leonardo Antonio Mamede [UNESP]
author_role author
author2 dos Santos, Priscila P. [UNESP]
Rafacho, Bruna P. M. [UNESP]
Gonçalves, Andrea F. [UNESP]
Silva, Renata A. C. [UNESP]
Chiuso-Minicucci, Fernanda
Gaiolla, Paula Schmidt Azevedo [UNESP]
Polegato, Bertha Furlan [UNESP]
Okoshi, Katashi [UNESP]
Pereira, Elenize J. [UNESP]
Paiva, Sergio Alberto Rupp de [UNESP]
Zornoff, Leonardo Antonio Mamede [UNESP]
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
University Estadual
dc.contributor.author.fl_str_mv Minicucci, Marcos Ferreira [UNESP]
dos Santos, Priscila P. [UNESP]
Rafacho, Bruna P. M. [UNESP]
Gonçalves, Andrea F. [UNESP]
Silva, Renata A. C. [UNESP]
Chiuso-Minicucci, Fernanda
Gaiolla, Paula Schmidt Azevedo [UNESP]
Polegato, Bertha Furlan [UNESP]
Okoshi, Katashi [UNESP]
Pereira, Elenize J. [UNESP]
Paiva, Sergio Alberto Rupp de [UNESP]
Zornoff, Leonardo Antonio Mamede [UNESP]
description Introduction:Our objective was to analyze the effect of spironolactone on cardiac remodeling after experimental myocardial infarction (MI), assessed by matricellular proteins levels, cardiac collagen amount and distribution, myocardial tissue metalloproteinase inhibitor-1(TIMP-1) concentration, myocyte hypertrophy, left ventricular architecture, and in vitro and in vivo cardiac function.Methods:Wistar rats were assigned to 4 groups: control group, in which animals were submitted to simulated surgery (SHAM group; n=9); group that received spironolactone and in which animals were submitted to simulated surgery (SHAM-S group, n=9); myocardial infarction group, in which animals were submitted to coronary artery ligation (MI group, n=15); and myocardial infarction group with spironolactone supplementation (MI-S group, n=15). The rats were observed for 3 months.Results:The MI group had higher values of left cardiac chambers and mass index and lower relative wall thicknesses compared with the SHAM group. In addition, diastolic and systolic functions were worse in the MI groups. However, spironolactone did not influence any of these variables. The MI-S group had a lower myocardial hydroxyproline concentration and myocyte cross-sectional area compared with the MI group. Myocardial periostin and collagen type III were lower in the MI-S group compared with the MI-group. In addition, TIMP-1 concentration in myocardium was higher in the MI-S group compared with the MI group.Conclusions:The predominant consequence of spironolactone supplementation after MI is related to reductions in collagens, with discrete attenuation of other remodeling variables. Importantly, this effect may be modulated by periostin and TIMP-1 levels. © 2013 Minicucci et al.
publishDate 2013
dc.date.none.fl_str_mv 2013-09-30
2014-05-27T11:30:45Z
2014-05-27T11:30:45Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1371/journal.pone.0076866
PLoS ONE, v. 8, n. 9, 2013.
1932-6203
http://hdl.handle.net/11449/76670
10.1371/journal.pone.0076866
WOS:000325423500179
2-s2.0-84884732041
2-s2.0-84884732041.pdf
1590971576309420
5016839015394547
1213140801402647
7438704034471673
0000-0002-5843-6232
url http://dx.doi.org/10.1371/journal.pone.0076866
http://hdl.handle.net/11449/76670
identifier_str_mv PLoS ONE, v. 8, n. 9, 2013.
1932-6203
10.1371/journal.pone.0076866
WOS:000325423500179
2-s2.0-84884732041
2-s2.0-84884732041.pdf
1590971576309420
5016839015394547
1213140801402647
7438704034471673
0000-0002-5843-6232
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv PLOS ONE
2.766
1,164
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1792961888805453824